At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
post operative analgesicsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Trypsin-Chymotrypsin On Postoperative Pain After Single Visit Endodontic Treatment A Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating post operative analgesics for Effect of Drug. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Achieving effective pain control after endodontic treatment is still a disruptive event to all the clinicians. There is a knowledge gap regarding the effect of protease on postoperative pain following root canal treatment, therefore, the efficacy of Trypsin-Chymotrypsin on post endodontic pain was evaluated clinically in a randomized triple-blind trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEffect of Drug
CountriesEgypt
Collaborators--
Timeline
Phase 4CompletedFinished
20222023202420252026
Enrollment StartJun 2021
Primary CompletionDec 2021
First PostedJul 2022
TodayJul 2026
First PostedJul 29, 2022
Enrollment StartJun 1, 2021
Primary CompletionDec 31, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 3.9 years ago
Interventions
post operative analgesicsdrug
post-operative pain killer